Hello, everyone, and how are you today? The view from the Pharmalot corporate campus is, unfortunately, a bit gloomy thanks to another spot of rain, but our spirits remain high. After all, as the Morning Mayor used to say: Every brand new day should be unwrapped like a precious gift. We have not issued the reminder in awhile, so it was about time. Meanwhile, there is much to do, as always. So time to get on with it. Here are some tidbits. Hope your day is smashing and stay in touch...
FDA Says Zithromax Can Cause Fatal Irregular Heart Rhythm (Reuters)
Some Experts Defend Niacin After Failed Heart Disease Study (Forbes)
Shire Specialty Exec Mike Yasick Dies Of Heart Attack (Philadelphia Inquirer)
EC Says Pharma Has Time To Mark Risky Drugs With Triangle (InPharma Technologist)
AEterna Zentaris Drops Myeloma Drug After Phase III Failure (Pharma Times)
Is Puma Biotechnology A Takeover Target? (Bloomberg News)
Drugmakers And Interpol Ramp Up Fight Against Counterfeits (Associated Press)
Astellas End Cancer Drug Pact With Ambit (Pharma Times)
Whooping Cough Vaccine Protection Wanes (Reuters)
J&J Faces Second Trial Over Hip Implants (Bloomberg News)
Major Pharma Plans R&D Facility And 50 Hires (Milwaukee Journal-Sentinel)
EDITOR'S NOTE: Please check this post for additional items during the day